United States v. Viral Thaker

Procedural entryThis page is a short order in United States v. Viral Thaker. Read the opinion of the Court — 579 F. App'x 449
Court of Appeals for the Sixth Circuit·Decided October 21, 2014·No. 13-1215·Unpublished

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 14a0793n.06

Nos. 13-1164/1173/1182/1215/1216

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT FILED UNITED STATES OF AMERICA, ) Oct 21, 2014 ) DEBORAH S. HUNT, Clerk Plaintiff-Appellee, ) ) ON APPEAL FROM THE v. ) UNITED STATES DISTRICT ) COURT FOR THE EASTERN BABUBHAI PATEL, BRIJESH RAWAL, KOMAL ) DISTRICT OF MICHIGAN ACHARYA, VIRAL THAKER, and LOKESH ) TAYAL, ) AMENDED OPINION ) Defendants-Appellants. )

Before: COLE, Chief Judge; BOGGS and STRANCH, Circuit Judges.

STRANCH, Circuit Judge. In these consolidated cases, five defendants pursue direct

appeals after they were convicted by a jury and sentenced for their roles in conspiracies to

commit health care fraud and to distribute prescription drugs in Detroit over a period of five

years. The leader of these conspiracies, Babubhai Patel, was a registered pharmacist and

businessman who owned or controlled at least twenty pharmacies in Michigan. He hired other

pharmacists, including his co-defendants Brijesh Rawal, Viral Thaker, and Lokesh Tayal, to

assist him in defrauding Medicare, Medicaid, and Blue Cross/Blue Shield of Michigan of

approximately $18.9 million. These co-conspirators unlawfully distributed millions of dosage

units of controlled substances. Komal Acharya was involved in a personal relationship with

Patel and assisted him as a member of the health care fraud conspiracy. Nos. 13-1164/1173/1182/1215/1216 United States v. Babubhai Patel, et al.

Patel, Rawal, Thaker, and Tayal challenge the district court’s denial of their motions to

suppress evidence obtained through a Title III wiretap on two cell phones used by Patel. They

contend that the government failed to prove necessity for the wiretaps, failed to inform the

issuing court that translators would monitor the phone lines, and failed to minimize nonpertinent

calls. Thaker, Tayal, and Acharya each argue that the government’s evidence was insufficient to

convict them. Patel challenges the procedural reasonableness of his sentence.1 We AFFIRM the

defendants’ convictions and Patel’s sentence.

I. BACKGROUND

The conspiracies began in January 2006 and ended in August 2011 when Patel and his

associates were arrested, effectively ending their illegal activities. The number of pharmacies

controlled by Patel varied over time, and he changed their corporate structures frequently. Patel

hired all of the staff and supervised the pharmacy operations.

The scheme to defraud insurers depended on the participation of physicians, pharmacists,

recruiters, and patients. Patel paid cash bribes to physicians to entice them to write patient

prescriptions for expensive medications and controlled substances that could be billed to

Medicare, Medicaid, or private insurers through the Patel pharmacies. He paid kickbacks to

managers of health-related companies so that they would send patients to his pharmacies, and he

employed “marketers” to recruit “patients” directly from the streets.

1 After oral argument, Rawal sought to adopt that portion of Patel’s brief discussing the sentencing argument. Fed. R. App. P. 28(i). Rawal did not raise any sentencing issues in his opening or reply briefs in this court, his counsel did not mention during oral argument that any error occurred during the sentencing, and he has not explained how Patel’s arguments apply to his own factual situation. Under the circumstances, Rawal’s belated Rule 28(i) letter is insufficient to preserve a sentencing issue for appeal. See United States v. Hough, 276 F.3d 884, 891 (6th Cir. 2002); United States v. Elder, 90 F.3d 1110, 1118 (6th Cir. 1996). -2- Nos. 13-1164/1173/1182/1215/1216 United States v. Babubhai Patel, et al.

Pharmacists facilitated the criminal activity by charging insurers for expensive

medications that were ordered from wholesale distributors and held in inventory but not

dispensed to patients. These surplus medications were later returned to the supplier for credit or

sold on the black market. Pharmacists also billed insurers for controlled substances that the

pharmacists knew were illegally prescribed. These controlled medications included

hydrocodone (Vicodin, Lortab), oxycodone (Oxycontin), alprazolam (Xanax), and codeine-

infused cough syrup. When filling prescriptions, the pharmacists usually “shorted” the number

of dosage units placed in the medication vials for patients, billed the insurers for the full drug

quantities prescribed, and then sold the excess pills on the street.

A significant portion of the prescription fraud was perpetrated through Visiting Doctors

for America (VDA), a physician group that purported to provide home doctor visits to patients.

Marketers recruited “patients” from homeless shelters and soup kitchens by offering them small

amounts of cash or controlled substances. The marketers transported the “patients” to a VDA

physician, who performed cursory examinations of the “patients” while they sat together in one

room. VDA staff provided the co-conspirators with dummy patient files and blank prescription

pads previously signed by a physician or physician’s assistant. Mehul Patel and later Arpit Patel,

neither of whom is a physician, wrote prescriptions for controlled medications and expensive

non-controlled medications on these blank, pre-signed prescription pads. The prescriptions were

taken to the Patel pharmacies, where the pharmacists used the dummy patient files to enter

patient profiles into the computer database, billed for all of the medications prescribed, but filled

only the controlled medications. The controlled substances were then distributed, or sold on the

street.

-3- Nos. 13-1164/1173/1182/1215/1216 United States v. Babubhai Patel, et al.

Patel paid his pharmacists salaries, bonuses, and twenty percent of pharmacy profits to

encourage them to engage in fraudulent practices. The pharmacies distributed nearly 500,000

dosage units of Schedule II controlled substances (including oxycodone), approximately

4.9 million dosage units of Schedule III controlled substances (including hydrocodone), nearly

2.3 million dosage units of Schedule IV controlled substances (including alprazolam), and

approximately 2.5 million dosage units of Schedule V controlled substances. Between 2006 and

2011, the Patel pharmacies billed Medicare approximately $37,770,557; Medicaid approximately

$23,134,691; and Blue Cross/Blue Shield of Michigan approximately $6,359,872.

Babubhai Patel was convicted of health care fraud conspiracy in violation of 18 U.S.C.

§ 1349 (count 1), drug conspiracy in violation of 21 U.S.C. § 846 (count 15), ten counts of aiding

and abetting health care fraud in violation of 18 U.S.C. § 1347 & § 2 (counts 2–5, 7–9, 12–14),

and fourteen counts of aiding and abetting the unlawful distribution of controlled substances in

violation of 21 U.S.C. § 841(a)(1) & 18 U.S.C. § 2 (counts 20–32, 34). He was acquitted on

three counts of aiding and abetting health care fraud (counts 6, 10–11) and five counts of aiding

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Viral Thaker, (6th Cir. 2014).

United States v. Viral Thaker (United States v. Viral Thaker) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Terry v. Ohio
392 U.S. 1 (Supreme Court, 1968)
United States v. Kahn
415 U.S. 143 (Supreme Court, 1974)
Scott v. United States
436 U.S. 128 (Supreme Court, 1978)
United States v. Shabani
513 U.S. 10 (Supreme Court, 1994)
Bates v. United States
522 U.S. 23 (Supreme Court, 1997)
Salinas v. United States
522 U.S. 52 (Supreme Court, 1997)
Rita v. United States
551 U.S. 338 (Supreme Court, 2007)
United States v. Yarbrough
527 F.3d 1092 (Tenth Circuit, 2008)
United States v. Warshak
631 F.3d 266 (Sixth Circuit, 2010)
United States v. Lopez
300 F.3d 46 (First Circuit, 2002)
United States v. Jones
641 F.3d 706 (Sixth Circuit, 2011)
United States v. William Anthony George
465 F.2d 772 (Sixth Circuit, 1972)
United States v. Joseph William Landmesser
553 F.2d 17 (Sixth Circuit, 1977)
United States v. Poulsen
655 F.3d 492 (Sixth Circuit, 2011)
United States v. Clay
667 F.3d 689 (Sixth Circuit, 2012)